Revenue (Annual)

Revenue: The sum of all revenue fields included for a company's operating activities.

ImmuCell Corporation (ICCC) had Revenue of $26.49M for the most recently reported fiscal year, ending 2024-12-31.

Quarterly Annual

Figures for fiscal year ending 2024-12-31

Income Statement Financials
Revenue	$26.49M
Net Income	$-2.16M
Cost of Goods Sold	$18.55M
Gross Profit	$7.94M
Operating Expenses	$28.13M
Operating Income	$-1.64M
Non-Operating Income/Expense	$-0.51M
Pre-Tax Income	$-2.15M
Normalized Pre-Tax Income	$-2.15M
Income after Taxes	$-2.16M
Income from Continuous Operations	$-2.16M
Consolidated Net Income/Loss	$-2.16M
Normalized Income after Taxes	$-2.16M
EBIT	$-1.64M
EBITDA	$1.09M
Weighted-Average Shares Outstanding (Basic)	8.17M
Weighted-Average Shares Outstanding (Diluted)	8.17M
Earnings per Share (EPS) (Basic)	$-0.26
Earnings per Share (EPS) (Diluted)	$-0.26
Balance Sheet Financials
Current Assets	$15.04M
Property, Plant, and Equipment	$25.35M
Long-Term Assets	$30.06M
Total Assets	$45.10M
Current Liabilities	$4.41M
Long-Term Debt	$9.04M
Long-Term Liabilities	$13.17M
Total Liabilities	$17.58M
Common Equity	$27.52M
Tangible Shareholders Equity	$27.40M
Shareholders Equity	$27.52M
Common Shares Outstanding	8.98M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$0.36M
Cash Flow from Investing Activities	$-0.46M
Cash Flow from Financial Activities	$2.88M
Beginning Cash	$0.98M
End Cash	$3.76M
Increase/Decrease in Cash	$2.78M
Stock-Based Compensation	$0.33M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	3.41
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.25
Debt to Equity Ratio	0.38
Gross Margin	29.97%
Operating Margin	-6.19%
EBIT Margin	-6.19%
EBITDA Margin	4.11%
Pre-Tax Profit Margin	-8.10%
Profit Margin	-8.14%
Free Cash Flow	$-0.10M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.59
Inventory Turnover	2.61
Receiveable Turnover	7.03
Days Sales in Receivables	51.96
Return on Equity	-7.84%
Return on Tangible Equity	-7.87%
Return on Assets	-4.78%
Return on Investments	-5.90%
Book Value Per Share	$3.06
Free Cash Flow per Share	$-0.01
Operating Cash Flow per Share	$0.04

Data from Zacks Investment Research, Inc.